News for Skye Bioscience, Inc. (SKYE)

SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. ( SKYE) (”œSkye”), a clinical-stage biopharmaceutical company focused on unlocking new t

**media[548310]**

**media[531562]**

Expected Phase 2 obesity data in Q2 2025 and Q4 2025 will shape clinical potential and development path of distinctive CB1 inhibitor SAN DIEGO, Jan. 13, 2025

Despite risks related to early-stage IP and low trading volume, SKYE's promising IP and near-term catalysts justify a speculative

Skye Bioscience chief development officer sells shares worth $97,721

Skye Bioscience CFO Kaitlyn Arsenault sells $216,652 in stock

**media[468993]**

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. ( SKYE) (”œSkye”), a clinical-stage biopharmaceutical company focused on unlocking new t

**media[465906]**

Skye Bioscience, Inc. (NASDAQ:SKYE) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsBernie Hertel - Head, Investor...

Skye Bioscience appoints new chairman to boost governance

Seasoned industry veteran adds significant global biotech and biopharma experience to Skye’s Board of Directors...

Loading... Loading... Shares of Quantum Corporation QMCO fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial re...

The Dow Jones index closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

The dynamics of the glaucoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising...

/PRNewswire/ -- The medical marijuana market is estimated to grow by USD 21,248.51 million from 2022 to 2027. The market grows at a CAGR of 21.86% during the...

Emerald Health Therapeutics, Inc. announced today that its Plan of Arrangement with Skye Bioscience, Inc. has closed and that it has entered into agreements to divest its remaining cannabis... | November 11, 2022

San Diego, California, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company...